BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26414658)

  • 1. Antineutrophil Cytoplasmic Antibody-Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy: How Significant Is the Clinical Problem?
    Balavoine AS; Glinoer D; Dubucquoi S; Wémeau JL
    Thyroid; 2015 Dec; 25(12):1273-81. PubMed ID: 26414658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN; Hsu TC; Chou HH; Tsay GJ
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
    Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism.
    Gao Y; Zhao MH; Guo XH; Xin G; Gao Y; Wang HY
    Endocr Res; 2004 May; 30(2):205-13. PubMed ID: 15473130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
    Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
    Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
    Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
    Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
    Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole.
    Wada N; Mukai M; Kohno M; Notoya A; Ito T; Yoshioka N
    Endocr J; 2002 Jun; 49(3):329-34. PubMed ID: 12201217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
    Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
    Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
    Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
    Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
    Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
    Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
    Kubota S
    Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between methimazole and antineutrophil cytoplasmic antibody-positive vasculitis].
    Chen LQ; Zhang XL; Wu HY; Guo S; Li XZ
    Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):446-9. PubMed ID: 19099784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
    Ye H; Gao Y; Guo XH; Zhao MH
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histological features of antineutrophil cytoplasmic antibody-associated vasculitis related to antithyroid drugs
.
    Hasegawa J; Hoshino J; Sekine A; Hayami N; Suwabe T; Sumida K; Mise K; Ueno T; Yamanouchi M; Hazue R; Sawa N; Ohashi K; Fujii T; Takaichi K; Ubara Y
    Clin Nephrol; 2018 Jun; 89(6):438-444. PubMed ID: 29648530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.